Dianthus Therapeutics Inc. Skyrocketed

Mon, Jan 22, 2024 at 07:21 PM

Dianthus Therapeutics Inc. (DNTH:NASDAQ) jumped higher at $16.4, a gain of 37.2%. On Mon, Jan 22, 2024, DNTH:NASDAQ touched a New 2-Week High of $16.4. The stock appeared on our News Catalysts scanner on Mon, Jan 22, 2024 at 08:11 AM in the 'PRIVATE PLACEMENT' category. From Tue, Jan 09, 2024, the stock recorded 50.00% Up Days and 55.56% Green Days

About Dianthus Therapeutics Inc. (DNTH:NASDAQ)

Magenta Therapeutics Inc is a clinical-stage biotechnology company.

Top 10 Gainers:

Sagimet Biosciences Inc. (SGMT:NASDAQ), 170.09%
Scopus BioPharma Inc. (SCPS:NASDAQ), 100%
Brera Holdings PLC (BREA:NASDAQ), 64.39%
Rail Vision Ltd. (RVSN:NASDAQ), 64.23%
Marpai Inc. (MRAI:NASDAQ), 48.28%
Fitell Corporation (FTEL:NASDAQ), 48%
Eightco Holdings Inc Com (New) (OCTO:NASDAQ), 43.96%
Phunware, Inc. (PHUN:NASDAQ), 41.55%
Remark Holdings, Inc. (MARK:NASDAQ), 40.26%
Dianthus Therapeutics Inc. (DNTH:NASDAQ), 37.24%